UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~March~~April 1321, 2009

WIFIMED HOLDINGS COMPANY, INC.

(Exact name of registrant as specified in its charter)

Nevada		0-49707		58-2412118
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)


2000 RiverEdge Parkway Suite GL 100A Atlanta, Georgia		30328
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: 770-919-7220

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 31.02 -– ~~Unregistered~~Termination ~~Sales~~ of ~~Equity~~a ~~Securities~~Material Definitive Agreement

On March 18, 132009, ~~the~~WiFiMed Holdings Company, ~~concluded three transactions that resulted in the sale of unregistered securities~~Inc. ~~About~~ ~~a month earlier~~(hereinafter, the “Company”) ~~concluded~~made aan ~~confidential~~8-K ~~settlement~~filing ~~agreement~~reporting ~~that~~under ~~also~~Item ~~resulted~~3.02 inthat the ~~sale~~Company ofhad ~~unregistered securities. These~~issued ~~transactions~~5 ~~are not related to one another, and~~million ~~none~~shares of ~~them is deemed by~~ the Company’s stock to bePrincipal aCapital ~~material~~Group, ~~definitive agreement within the meaning of Section 1 of Form 8-K~~Inc. ~~However,~~ ~~they~~(“PCG”) ~~do in~~pursuant ~~aggregate~~to ~~exceed~~a 5%March of13, ~~the~~2009, ~~number~~amendment ofto ~~shares~~an ~~outstanding~~agreement ofbetween the ~~class~~Company ~~of equity securities sold,~~ and ~~therefore~~PCG ~~trigger, under Item 3.02(b), the obligation to~~that ~~report~~had ~~such~~originally ~~sales~~been ~~prior~~entered tointo ~~the~~on ~~filing~~or ofabout ~~the~~October ~~Company’s~~2, ~~10-K report~~2008.

~~The~~On ~~Company entered into an Amendment~~April ~~to Employment Agreement with its president and CEO~~21, ~~Gregory D. Vacca that resulted in the award and delivery to Mr. Vacca of five million (5~~2009,~~000,000) shares~~ of the Company’s ~~common~~sent ~~stock~~notice ~~on March 13, 2009. Pursuant~~ to ~~a proposal~~PCG bythat ~~Mr.~~it ~~Vacca~~was ~~made~~terminating toits ~~(and accepted in principle by) the Company’s Board~~business ofrelationship ~~Directors~~with ~~(the~~PCG ~~“Board”) on or about February 9, 2009, Mr. Vacca~~ and ~~the Company~~was ~~agreed that Mr. Vacca would be paid 2~~seeking,~~500,000~~ ~~shares~~among ofother ~~unregistered common stock in exchange for his forgiveness of $25~~things,~~000~~ ~~due but then-unpaid in compensation owed pursuant to~~ the ~~terms~~return ~~of the employment agreement entered into by the Company~~ and ~~Mr. Vacca effective on~~ /or ~~about October 15,~~ ~~2007. Mr.~~cancellation ~~Vacca also agreed, in recognition~~ of the ~~economic environment~~5 ~~and~~million ~~current~~shares ~~financial~~given ~~circumstances, and as part of an effort~~ to ~~demonstrate~~ ~~his commitment to the Company, to reduce his claim for back pay, including bonus pay, by an additional $50,000 for no additional consideration~~PCG. In addition, the Company also agreed to provide Mr. Vacca 2,500,000 shares of unregistered common stock in exchange for his forgiveness of $25,000 debt in connection with the non-payment by the Company and its subsidiaries of reimbursable business expenses.

~~The Company and its financial advisor,~~Item ~~Principal Capital Group, Inc~~8.01 ~~(“PCG”),~~– ~~entered~~Other into an amendment on March 13, 2009 to their existing engagement agreement pursuant to which the Company paid 5 million shares of the Company’s common stock to PCG. The Company and PCG agreed to amend their agreement to provide that 2,500,000 of such shares would be deemed the final installment of the retainer for expenses, and the remaining 2,500,000 of such shares would be deemed a credit (valued at $0.03 per share) against certain cash payments due to PCG in the event that certain funding transactions close. Pursuant to the amendment, if no qualified funding transactions close within six months, those shares will be forfeited.Events

~~Also~~On ~~effective~~ March 13 16, 2009, the ~~Company~~ ~~paid~~President ~~2,750,000~~and ~~shares~~CEO of the Company’s, ~~common~~Gregory ~~stock to Mr~~D. ~~Steven~~Vacca, ~~K. Eckert~~reported ~~in two related transactions pursuant~~ to ~~which (a)~~ the Company’s ~~wholly-owned~~ ~~subsidiary~~shareholders ~~EncounterPRO~~in ~~Healthcare~~a ~~Resources,~~Pre ~~Inc.~~14C ~~(“EHRI”) purchased~~filing ~~certain~~that ~~assets~~that ~~and~~the ~~acquired~~Board ~~certain obligations~~ of ~~Clinical Solutions,~~Directors ~~Inc., and~~ (bthe “Board”) ~~Mr.~~had ~~Eckert~~approved ~~and EHRI entered into~~ an amendment to athe ~~promissory~~Company’s ~~note~~Articles of ~~evidencing~~Incorporation ato ~~debt~~change ofthe ~~approximately~~Company’s ~~$53,000~~name ~~owed~~from by“WIFIMed ~~EHRI~~Holdings toCompany, MrInc.” ~~Eckert. Pursuant~~ to ~~the~~“PROvisor ~~terms~~Diversified ofTechnologies ~~the~~Corp;” ~~amendment,~~to ~~the~~cancel ~~maturity~~all ~~date~~classes of Preferred ~~the~~Stock; ~~promissory~~and ~~note~~to isreverse ~~extended~~the ~~for~~issued ~~about five months,~~ and ~~the~~outstanding ~~amounts~~common ~~owed~~stock by ~~EHRI~~ toa Mrratio of 250:1. In ~~Eckert~~the ~~are~~same ~~reduced~~PRE ~~(pursuant~~14C tofiling, aMr. ~~formula~~Vacca ~~specified~~reported inthat the Board ~~amendment)~~had inresolved ~~the~~to ~~event~~elect ~~that~~to convert the Company’s ~~stock~~to ~~appreciates~~an ininvestment ~~value~~company ~~in the 30~~under ~~days~~sections ~~prior~~55-65 toof the ~~new~~Investment ~~maturity~~Company ~~date. The~~Act ~~acquisition~~ of ~~assets~~1940 ~~and obligations~~with ~~of Clinical Solutions, Inc. does not meet~~ the ~~standards~~Securities ofand ~~materiality~~Exchange ~~for~~Commission ~~purposes~~and ofto ~~Section~~treat 1the oftwo ~~Form~~current ~~8-K,~~operating ~~nor~~subsidiary ~~does such purchase~~companies ~~qualify~~(EncounterPRO asHealthcare ~~the~~Resources, ~~acquisition~~Inc. ~~of a~~ (“~~business~~EncounterPRO”) ~~under~~and ~~the~~CyberMedx ~~guidance of Rule 11-01(d)~~Medical ofSystems, ~~Regulation S-X~~Inc. ~~Moreover,~~ ~~even if such acquisition were deemed the acquisition of a~~ (“~~business,~~CyberMedx”)) ~~the~~as ~~purchase~~portfolio ~~does~~companies ~~not~~and ~~approach~~subsequently ~~meeting the~~to ~~20%~~spin ~~threshold~~off each ~~requiring disclosure~~ of ~~financial~~these ~~statements~~portfolio ~~pursuant~~companies toas ~~Rule 3-05(b)(2)~~a ~~of Regulation S~~one-~~X. Mr.~~time ~~Eckert~~special isdividend ~~the~~to ~~President and~~the ~~principal~~shareholders ~~shareholder~~as ofnew ~~Clinical~~public ~~Solutions, Inc~~companies.

~~The~~On April ~~Company~~21, ~~entered~~2009, ~~into~~the aBoard ~~confidential~~rescinded, ~~settlement~~reversed ~~with James D. Copenhaver~~ and ~~Carolyn~~ J.voided ~~Copenhaver~~(1) ~~concerning~~its ~~the~~approval ~~Copenhavers’~~of ~~claims against~~ the ~~Company~~ ~~effective~~aforesaid ~~February~~amendments ~~9, 2009. Pursuant~~ to the ~~agreement,~~Company’s ~~the~~Articles ~~Company provided~~of ~~three~~Incorporation ~~million~~and ~~unregistered~~(2) ~~shares~~its election ofto convert the Company's ~~common stock~~ to ~~Mr. Copenhaver,~~an ~~which~~investment ~~shares~~company ~~are forfeitable~~ under ~~certain~~sections ~~conditions~~55-56 ~~described in~~of the ~~confidential~~Investment ~~settlement~~Company ~~agreement~~Act of 1940.

With respect to each of these transactions, the issuances of the shares in were exempt from registration under the Securities Act of 1933, as amended (the “Act”), pursuant to Section 4(2) the Act. The shares issued have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

The Company shall furnish a copy of any omitted schedule or exhibit to the Commission upon request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:		~~March~~April 1821, 2009
		WiFiMed Holdings Company, Inc.
		Registrant
By:		/s/ ~~Gregory~~Kathleen DJ. ~~Vacca~~St. John
		Gregory D. Vacca President and CEO
		Kathleen J. St. John Secretary

Filing Compare · WIFIMED HOLDINGS COMPANY, INC.